Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $6.4 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $6.4 million, changed 0.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.7 million (down 11.04% YoY), and the FY2025 annual result was $24.9 million, down 20.93% from the prior year.
• Depreciation & Amortization (CF) rose to $6.4 million in Q1 2026 per TWST's latest filing, from $6.2 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $8.5 million in Q3 2023 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $6.6 million and a median of $6.4 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 103.7% in 2022, then fell 26.94% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.3 million in 2022, then soared by 54.4% to $8.2 million in 2023, then dropped by 21.92% to $6.4 million in 2024, then slipped by 2.92% to $6.2 million in 2025, then climbed by 3.55% to $6.4 million in 2026.
• Business Quant data shows TWST's Depreciation & Amortization (CF) at $6.4 million in Q1 2026, $6.2 million in Q4 2025, and $6.0 million in Q3 2025.